Nội dung chính của bài viết
Background: Chronic urticaria (CU) is defined by recurrent episodes lasting for six weeks or more and generally characterized by the sudden appearance of hives (wheal), angioedema or both. Most are idiopathic, however, one of the causes of chronic urticaria can be parasitic infection, especially Toxocariasis. Albendazol is used as a treatment for Toxocariasis. Therefore, the detection of causes, risk factors and specific treatment of the causes helps to solve chronic urticaria. Objectives: (1) To determine of Toxocara seropositivity in patients with chronic urticaria and identify the risk factors for toxocariasis; (2) To evaluate the results of oral albendazol in the treatment of toxocariasis in chronic urticatia. Materials and Method: A descriptive cross-sectional study of 66 chronic urticaria patients who had the result of serology for Toxocara. Results: The seroprevalence of Toxocaraiasis in this population was 19.7%. Factors such as a history of consuming the raw vegetables, raising dogs and cats habit or soil-contacting frequently were at higher risk of toxocariasis in patients with chronic urticaria. Clinical symptoms such as itching and hives in patients were significantly reduced. 30.8% of patients had ELISA results (-) after 3 months of completing treatment; 23.07% of patients had liver dysfunction; and 15.4% of patients reported side effects of epigastric pain or digestive disorders during treatment. Conclusion: The seroprevalence of Toxocaraiasis in this population was 19.7%. Several factors have been identified to be associated with Toxocara seropositivity. Albendazol in the treatment of Toxocara infections is highly effective and relatively safe.
Chi tiết bài viết
Chronic urticaria, Toxocara, Toxocariasis
Tài liệu tham khảo
2. Kolkhir Pavel, Galina Balakirski, et al. (2016), "Chronic spontaneous urticaria and internal parasites–a systematic review", Allergy. 71(3), pp. 308-322.
3. M Oteifa Nihad, Manal A Moustafa, et al. (1998), "Toxocariasis as a possible cause of allergic diseases in children", Journal of the Egyptian Society of Parasitology. 28(2), pp. 365-372.
4. Zuberbier Torsten, Werner Aberer, et al. (2018), "The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria", Allergy. 73(7), pp. 13931414.
5. Duong Tran Trong (2014), “Study on the current situation, some risk factors for toxocariasis in humans, and the effectiveness of treatment with albendazole in 2 communes of An Nhon district, Binh Dinh province (2011-2012)”, Doctor of Medicine Thesis, National Institute of MalariaParasitology-Entomology.
6. Hoa Nguyen Thai (2017), “ Toxocara canis seropositivity in urticaria patients at Quy Hoa National Hospital of Leprosy and Dermatology 2016-2017”.
7. Quan Nguyen Thi Thanh (2020), “ Study on the situation and factors related to Toxocara canis, Strongyloides stercoralis, and Echinococcus infection in urticaria patients at the dermatology clinic of the Hospital for Psychiatry and Dermatology in Hau Giang province in 2019-2020”, Thesis of Master of Medicine, Can Tho University of Medicine and Pharmacy.
8. Ly Le Thi Cam (2016), "Study on Toxocara canis infection in urticaria patients at Can Tho University of Medicine and Pharmacy hospital in 2014-2015," Journal of Can Tho Medical and Pharmacy Conference. (3–4), p. 358–363.
9. Son Luong Truong (2013), “ Understanding the epidemiological, clinical, and subclinical factors and treatment results for patients with intestinal parasites infected at the Institute of Malaria, Parasitology and Entomology, Ho Chi Minh City”, Medical Journal of Ho Chi Minh City, 17(1), pp. 87-94.
10. Tuan Bui Van (2018), “The current situation, some factors related to toxocariasis (Toxocara canis) larvae infection in humans in Mo Duc district, Quang Ngai province, 2016 and the effectiveness of some interventions”, Thesis Doctor of Public Health, Central Institute of Hygiene and Epidemiology.